HOME >> BIOLOGY >> NEWS
Little-known substance regulates inflammatory response

In the September 29 issue of the journal Science, researchers from the University of Chicago show that a little-known molecule called A20 plays a critical role in regulating inflammation. This unexpected finding suggests an entirely new target for drugs designed to treat inflammatory diseases such as ulcerative colitis, Crohn's disease, rheumatoid arthritis and even septic shock.

First discovered ten years ago, A20 was largely ignored as an insignificant link in the chain reaction of inflammation. Scientists thought it was only produced by certain types of white blood cells in a few tissues such as the intestines and thymus.

"A20 had been studied in only a limited way at the cellular level and never in a live animal," said Averil Ma, M.D., assistant professor of medicine and immunology at the University of Chicago, who uses transgenic mice to study the basic biology of inflammatory bowel disease.

"We created mice that lacked the A20 gene, hoping to identify its function in intestinal lymphocytes," he said. Instead they discovered that the molecule was much more widespread than anticipated and that it was a critical regulator of inflammation in multiple tissues.

"We found that rapid expression of A20," said Ma, "was absolutely essential for down-regulating the inflammatory response and averting the damage unrestrained inflammation can cause in multiple tissues."

Within three to six weeks after birth, mice without the gene for A20 spontaneously developed severe inflammation and tissue damage in multiple organs. When exposed to substances that mimic infection or trigger inflammation, mice lacking A20 developed symptoms identical to septic shock -- plummeting blood pressure, widespread inflammation, kidney damage, decreased heart function -- and died within two hours. In contrast, normal mice with A20 had no symptoms despite exposure to ten-fold higher doses of these same stimulants.

Inflammation is part of the normal response
'"/>

Contact: John Easton
jeaston@uchospitals.edu
773-702-6241
University of Chicago Medical Center
28-Sep-2000


Page: 1 2 3

Related biology news :

1. Antimalarial substances found in New Caledonian sponges
2. Sponge substance works well with yew derivative to thwart cancer cell proliferation
3. Common airborne substance makes asthmatics more sensitive to house dust mites: study
4. SCOPE/IUPAC report on endocrine active substances to be published
5. IUPAC report- Natural and synthetic substances
6. Mosquitoes repelled by tomato-based substance
7. A genetic risk factor for substance abuse
8. Stratified seawater disrupts the transport of imposex substances
9. UC Riverside scientists discover wound-healing substance
10. Fred Hutchinson Cancer Research Center, University of Washington join in national effort to study health impact of toxic substances
11. Vitamin-like substance leads to dramatic improvements in patients with muscular disorder

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/16/2019)... (PRWEB) , ... June 14, 2019 , ... ... multi-pillar Oracle Cloud customer, will deliver a joint presentation with Versiti’s CIO at ... June 16-19 at the Rosen Shingle Creek Resort. , Versiti Vice President and ...
(Date:6/11/2019)... Ind. (PRWEB) , ... June 10, 2019 , ... Improved ... in the July 2019 issue of AAPS PharmSciTech. The article was published online on ... of Improved Pharma, along with Xiaoming Sean Chen of Purdue University. , The ...
(Date:6/4/2019)... ... June 04, 2019 , ... ... appointment of Susan Murphy as the new President of Molecular Devices, replacing Greg ... Devices’ parent company, Danaher Corporation. , Since joining Molecular Devices in a scientific ...
Breaking Biology News(10 mins):
(Date:7/9/2019)... , ... July 08, 2019 , ... Today, at the ... the National Corn Growers Association (NCGA) announced the winners of the Consider ... a product or process using field corn to produce biobased materials. , “Corn is ...
(Date:7/2/2019)... ... July 02, 2019 , ... Leading Regenerative Veterinary Medicine company, VetStem Biopharma ... Biotech. The film focuses on regenerative veterinary medicine as a means of improving ... recently included in the Brentwood and Pacific Palisades International Film Festival in Los ...
(Date:6/18/2019)... ... June 17, 2019 , ... IVERIC bio, ... an agreement for production and manufacturing of GMP-grade adeno-associated virus (AAV) vector for ... dominant retinitis pigmentosa (RHO-adRP) and IC-200 for the treatment of BEST1 related retinal ...
(Date:6/12/2019)... , ... June 12, 2019 , ... ... helium-based leak testing instruments for the Pharmaceutical, Biotechnology, Medical Device and Food Packaging ... has been signed. The agreement will grant exclusive rights for Zillion to represent ...
Breaking Biology Technology:
Cached News: